You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
ESD, not EMR, should be the first-line therapy for early gastric neoplasia

Authors

  • Neal Shahidi Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Michael J Bourke Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Michael J Bourke, Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, NSW 2145, Australia; michael{at}citywestgastro.com.au
View Full Text

Citation

Shahidi N, Bourke MJ
ESD, not EMR, should be the first-line therapy for early gastric neoplasia
Gut 2020;69:1711-1712.

Publication history

  • Received August 13, 2019
  • Accepted August 15, 2019
  • First published September 3, 2019.
Online issue publication 
February 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.